Template:Antiphospholipid syndrome: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 11: Line 11:
!
!
[[Antiphospholipid syndrome|Home]]
[[Antiphospholipid syndrome|Home]]
|-
!
|- bgcolor="Pink"
!
[[Antiphospholipid syndrome (patient information)|Patient Information]]
|-  
|-  
!
!
Line 23: Line 17:
!
!
[[Antiphospholipid syndrome overview|Overview]]
[[Antiphospholipid syndrome overview|Overview]]
|-
!
|- bgcolor="Pink"
!
[[Antiphospholipid syndrome historical perspective|Historical Perspective]]
|-
!
|- bgcolor="Pink"
!
[[Antiphospholipid syndrome classification|Classification]]
|-  
|-  
!
!
Line 65: Line 47:
!
!
[[Antiphospholipid syndrome risk factors|Risk Factors]]
[[Antiphospholipid syndrome risk factors|Risk Factors]]
|-
!
|- bgcolor="Pink"
!
[[Antiphospholipid syndrome screening|Screening]]
|-  
|-  
!
!
Line 107: Line 83:
!
!
[[Antiphospholipid syndrome laboratory findings|Laboratory Findings]]
[[Antiphospholipid syndrome laboratory findings|Laboratory Findings]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Antiphospholipid syndrome electrocardiogram|Electrocardiogram]]
|-  
|-  
!
!
Line 163: Line 133:
|-  
|-  
!
!
|- bgcolor="PaleTurquoise"
!
[[Antiphospholipid syndrome surgery|Surgery]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Antiphospholipid syndrome primary prevention|Primary Prevention]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Antiphospholipid syndrome secondary prevention|Secondary Prevention]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Antiphospholipid syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Antiphospholipid syndrome future or investigational therapies|Future or Investigational Therapies]]
|-
!


|- bgcolor="CadetBlue"
|- bgcolor="CadetBlue"

Revision as of 06:22, 31 August 2012